NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
Cognitive deficits associated with frontal lobe dysfunction are a determinant of long-term disability in schizophrenia and are not effectively treated with available medications. Clinical studies show that many aspects of these deficits are transiently induced in healthy individuals treated with N -methyl- d -aspartate (NMDA) antagonists. These findings and recent genetic linkage studies strongly implicate NMDA receptor deficiency in schizophrenia and suggest that reversing this deficiency is pertinent to treating the cognitive symptoms of schizophrenia. Despite the wealth of behavioral data on the effects of NMDA antagonist treatment in humans and laboratory animals, there is a fundamental lack of understanding about the mechanisms by which a general state of NMDA deficiency influences the function of cortical neurons. Using ensemble recording in freely moving rats, we found that NMDA antagonist treatment, at doses that impaired working memory, potentiated the firing rate of most prefrontal cortex neurons. This potentiation, which correlated with expression of behavioral stereotypy, resulted from an increased number of irregularly discharged single spikes. Concurrent with the increase in spike activity, there was a significant reduction in organized bursting activity. These results identify two distinct mechanisms by which NMDA receptor deficiency may disrupt frontal lobe function: an increase in disorganized spike activity, which may enhance cortical noise and transmission of disinformation; and a decrease in burst activity, which reduces transmission efficacy of cortical neurons. These findings provide a physiological basis for the NMDA receptor deficiency model of schizophrenia and may clarify the nature of cortical dysfunction in this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rats treated with NMDAR antagonists, PFC neurons display the elevated and irregular spiking activity and the reduced coordinated burst firing, suggesting that NMDA hypofunction in PFC may drive disorganized network activity 174.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [174]
In the citing paper
“In rats treated with NMDAR antagonists, PFC neurons display the elevated and irregular spiking activity and the reduced coordinated burst firing, suggesting that NMDA hypofunction in PFC may drive disorganized network activity 174.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [174]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex
McCormick, D. A., Connors, B. W., Lighthall, J. W., & Prince, D. A. (1985) · Journal of Neurophysiology · doi:10.1152/jn.1985.54.4.782 · Cited by 1,933
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Self-citationGlutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Intrinsic firing patterns of diverse neocortical neurons
Connors, B. W., & Gutnick, M. J. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90185-d · Cited by 1,448
Research works printed but not linked: 3
- Abel, K. M., Allin, M. P., Kucharska-Pietura, K., David, A., Andrew, C., Williams, S., Brammer, M. J. & Phillips, M. L. (2003) NeuroReport 14, 387-389.12634489
- Grubb, B. D., Riley, R. C., Hope, P. J., Pubols, L. & Duggan, A. W. (1996) Neuroscience 74, 1077-1086.8895876
- Steriade, M., Amzica, F. & Contreras, D. (1994) Electroencephalogr. Clin. Neurophysiol. 90, 1-16.7509269
Cited by
Items 101–200 of 470
Jiménez-Sánchez, L., Campa, L., Auberson, Y. P., & Adell, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.123 · Cited by 85
Homayoun, H., & Moghaddam, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhi087 · Cited by 85
Self-citationGeerts, H., & Grossberg, G. T. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006288734 · Cited by 84
Xi, D., Zhang, W., Wang, H.-X., Stradtman, G. G., & Gao, W.-J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570900042x · Cited by 83
Prefrontal cognitive systems in schizophrenia : Towards human genetic brain mechanisms
Tan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2009) · Cognitive Neuropsychiatry · doi:10.1080/13546800903091665 · Cited by 83
Hunt, M. J., & Kasicki, S. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113495117 · Cited by 83
Neural circuit dysfunction in schizophrenia: Insights from animal models
Sigurdsson, T. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.059 · Cited by 83
Agnoli, L., Mainolfi, P., Invernizzi, R. W., & Carli, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.236 · Cited by 82
Homayoun, H., & Moghaddam, B. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0842-06.2006 · Cited by 80
Self-citationDendritic NMDA receptors in parvalbumin neurons enable strong and stable neuronal assemblies
Cornford, J. H., Mercier, M. S., Leite, M., Magloire, V., Häusser, M., & Kullmann, D. M. (2019) · eLife · doi:10.7554/elife.49872 · Cited by 80
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update
Ang, M. J., Lee, S., Kim, J.-C., Kim, S., & Moon, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200814175114 · Cited by 78
NMDA Receptors Enhance Spontaneous Activity and Promote Neuronal Survival in the Developing Cochlea
Zhang-Hooks, Y.-X., Agarwal, A., Mishina, M., & Bergles, D. E. (2016) · Neuron · doi:10.1016/j.neuron.2015.12.016 · Cited by 79
Lopez-Gil, X., Artigas, F., & Adell, A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361416 · Cited by 77
Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition
Marek, G. J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.058 · Cited by 78
Santana, N., Troyano‐Rodriguez, E., Mengod, G., Celada, P., & Artigas, F. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.030 · Cited by 77
Quirk, M. C. (2009) · Frontiers in Systems Neuroscience · doi:10.3389/neuro.06.013.2009 · Cited by 75
Pozzi, L., Dorocic, I. P., Wang, X., Carlén, M., & Meletis, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083879 · Cited by 74
“In accordance with this theory, acute ketamine administration rapidly increases glutamatergic neurotransmission in the prefrontal cortex of rodents, a process most likely mediated by presynaptic NMDA autoreceptors and/or NMDAR expressed on GABAergic interneurons [40], which are known to shape circuit function by chang…”
BackgroundDong, X., Li, Y.-C., Snyder, M. A., Gao, R. Y., Adelman, A. E., Zhang, W., Shumsky, J. S., & Gao, W. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.12 · Cited by 74
Carli, M., & Invernizzi, R. W. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00058 · Cited by 74
Carli, M., Calcagno, E., Mainolfi, P., Mainini, E., & Invernizzi, R. W. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2065-7 · Cited by 73
Parsegian, A., Glen, W. B., Lavin, A., & See, R. E. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.003 · Cited by 73
Hiyoshi, T., Kambe, D., Karasawa, J.-I., & Chaki, S. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.037 · Cited by 72
López-Gil, X., Artigas, F., & Adell, A. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009267 · Cited by 70
NMDARs Mediate the Role of Monoamine Oxidase A in Pathological Aggression
Bortolato, M., Godar, S. C., Melis, M., Soggiu, A., Roncada, P., Casu, A., Flore, G., Chen, K., Frau, R., Urbani, A., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0225-12.2012 · Cited by 70
The potential role of lamotrigine in schizophrenia
Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69
Hunt, M. J., Falinska, M., Łęski, S., Wójcik, D. K., & Kasicki, S. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110362126 · Cited by 69
Kandratavicius, L., Lopes‐Aguiar, C., Bueno-Júnior, L. S., Romcy-Pereira, R. N., Hallak, J. E. C., & Leite, J. P. (2012) · Brazilian Journal of Psychiatry · doi:10.1016/j.rbp.2012.04.007 · Cited by 69
Higgins, G. A., Carroll, N. K., Brown, M., MacMillan, C., Silenieks, L. B., Thevarkunnel, S., Izhakova, J., Magomedova, L., DeLannoy, I., & Sellers, E. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.640241 · Cited by 69
Kiss, T., Hoffmann, W. E., Scott, L., Kawabe, T. T., Milici, A. J., Nilsen, E. A., & Hajós, M. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00014 · Cited by 68
Hernandez, C. M., McQuail, J. A., Schwabe, M. R., Burke, S. N., Setlow, B., & Bizon, J. L. (2018) · eNeuro · doi:10.1523/eneuro.0164-18.2018 · Cited by 69
Arco, A. D., Segovia, G., & Mora, F. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1288-3 · Cited by 67
Bishop, S. F., Lauzon, N. M., Bechard, M., Gholizadeh, S., & Laviolette, S. R. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhq060 · Cited by 67
Xi, D., Keeler, B., Zhang, W., Houle, J. D., & Gao, W.-J. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.09.013 · Cited by 66
Grent-‘t-Jong, T., Brickwedde, M., Metzner, C., & Uhlhaas, P. J. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.03.026 · Cited by 64
Guidi, M., Kumar, A., & Foster, T. C. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3523-14.2015 · Cited by 63
“…task (M. Wang et al., 2013), there is evidence that NMDAR blockade results in disinhibition, increasing neural activity and the release of glutamate (Moghaddam et al., 1997; Jackson et al., 2004), possibly by reducing NMDAR activity on inhibitory interneurons (Povysheva and Johnson, 2012).”
BackgroundLeicht, G., Karch, S., Karamatskos, E., Giegling, I., Möller, H., Hegerl, U., Pogarell, O. M., Rujescu, D., & Mulert, C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.10.002 · Cited by 64
D'Agostino, G., Cristiano, C., Lyons, D. J., Citraro, R., Russo, E., Avagliano, C., Russo, R., Raso, G. M., Meli, R., De Sarro, G., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.04.005 · Cited by 63
Ahnaou, A., Huysmans, H., de Casteele, T. V., & Drinkenburg, W. H. I. M. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0002-9 · Cited by 63
The prefrontal cortex: a target for antipsychotic drugs
Artigas, F. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01455.x · Cited by 62
Vieira, P. A., Corches, A., Lovelace, J. W., Westbrook, K. B., Mendoza, M., & Korzus, E. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.12.012 · Cited by 62
Sivarao, D. V., Frenkel, M. Y., Chen, P., Healy, F. L., Lodge, N. J., & Zaczek, R. C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.006 · Cited by 61
Jodo, E. (2013) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2013.06.002 · Cited by 60
Blot, K., Kimura, S.-I., Bai, J., Kemp, A., Manahan-Vaughan, D., Giros, B., Tzavara, E., & Otani, S. (2015) · Cerebral Cortex · doi:10.1093/cercor/bht329 · Cited by 58
Kamiyama, H., Matsumoto, M., Otani, S., Kimura, S.-I., Shimamura, K.-I., Ishikawa, S., Yanagawa, Y., & Togashi, H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.012 · Cited by 57
Ketamine-induced distractibility: An oculomotor study in monkeys
Condy, C., Wattiez, N., Rivaud-Péchoux, S., & Gaymard, B. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.036 · Cited by 57
Skoblenick, K., & Everling, S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1510-12.2012 · Cited by 55
Impaired associative learning in schizophrenia: behavioral and computational studies
Diwadkar, V. A., Flaugher, B., Jones, T., Zalányi, L., Ujfalussy, B. B., Keshavan, M. S., & Érdi, P. (2008) · Cognitive Neurodynamics · doi:10.1007/s11571-008-9054-0 · Cited by 55
Calcagno, E., Carli, M., & Invernizzi, R. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03600.x · Cited by 54
Homayoun, H., & Moghaddam, B. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06679.x · Cited by 54
Self-citationMechanisms of Functional Hypoconnectivity in the Medial Prefrontal Cortex of Mecp2 Null Mice
Sceniak, M. P., Lang, M., Enomoto, A. C., James Howell, C., Hermes, D. J., & Katz, D. M. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhv002 · Cited by 53
Brown, J. W., Whitehead, C. A., Basso, A. M., Rueter, L. E., & Zhang, M. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000739 · Cited by 53
Grannan, M. D., Mielnik, C. A., Moran, S. P., Gould, R. W., Ball, J., Lu, Z., Bubser, M., Ramsey, A. J., Abe, M., Cho, H. P., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00230 · Cited by 52
Tanaka, D. H., Toriumi, K., Kubo, K.-I., Nabeshima, T., & Nakajima, K. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2786-11.2011 · Cited by 52
Ghoshal, A., & Conn, P. J. (2015) · Future Neurology · doi:10.2217/fnl.14.63 · Cited by 52
Evaluation of in vitro neuronal platforms as surrogates for in vivo whole brain systems
Belle, A. M., Enright, H. A., Sales, A. P., Kulp, K. S., Osburn, J. J., Kuhn, E. A., Fischer, N. O., & Wheeler, E. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-28950-5 · Cited by 52
Excitation-Inhibition Discoordination in Rodent Models of Mental Disorders
Fenton, A. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.013 · Cited by 50
The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development
Egerton, A., & M. Stone, J. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800784961 · Cited by 49
Bator, E., Latusz, J., Wędzony, K., & Maćkowiak, M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.013 · Cited by 49
Striatum-projecting prefrontal cortex neurons support working memory maintenance
Wilhelm, M., Sych, Y., Fomins, A., Warren, J. L. A., Lewis, C., Capdevila, L. S., Boehringer, R., Amadei, E. A., Grewe, B. F., O’Connor, E. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42777-3 · Cited by 48
Peng, H., Bian, X.-L., Ma, F.-C., & Wang, K.-W. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.72 · Cited by 48
Excitation and Inhibition Imbalance in Rett Syndrome
Li, W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.825063 · Cited by 47
Wang, X., Pinto-Duarte, A., Sejnowski, T. J., & Behrens, M. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4907 · Cited by 46
All-optical synaptic electrophysiology probes mechanism of ketamine-induced disinhibition
Fan, L. Z., Nehme, R., Adam, Y., Jung, E. S., Wu, H., Eggan, K., Arnold, D. B., & Cohen, A. E. (2018) · Nature Methods · doi:10.1038/s41592-018-0142-8 · Cited by 46
Blot, K., Bai, J., & Otani, S. (2013) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2013.04.003 · Cited by 46
Kotermanski, S. E., Johnson, J. W., & Thiels, E. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.005 · Cited by 46
Prefrontal mechanisms of comorbidity from a transdiagnostic and ontogenic perspective
MacDonald, A. N., Goines, K., Novacek, D. M., & Walker, E. F. (2016) · Development and Psychopathology · doi:10.1017/s0954579416000742 · Cited by 44
Arco, A. D., Mora, F., Mohammed, A. H., & Fuxé, K. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0533-3 · Cited by 44
Dawson, N., McDonald, M., Higham, D. J., Morris, B., & Pratt, J. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.26 · Cited by 44
Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia
Brady, A. M., McCallum, S. E., Glick, S. D., & O’Donnell, P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1195-7 · Cited by 43
“Abnormal prefrontal neuronal firing is also observed in multiple animal models of schizophrenia (O’Donnell et al. 2002; Jackson et al. 2004; Goto and Grace 2006; Moore et al. 2006), and PFC-dependent cognitive performance is disrupted in these animal models (Chambers et al.”
BackgroundTop-Down Suppression of Sensory Cortex in an NMDAR Hypofunction Model of Psychosis
Ranson, A., Broom, E., Powell, A. L., Chen, F., Major, G., & Hall, J. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby190 · Cited by 43
Bygrave, A. M., Kilonzo, K., Kullmann, D. M., Bannerman, D. M., & Kätzel, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00835 · Cited by 43
Homayoun, H., & Moghaddam, B. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.016 · Cited by 43
Self-citationLee, Y.-A., & Goto, Y. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07750.x · Cited by 43
Davies, D. A., Greba, Q., & Howland, J. G. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00183 · Cited by 43
Brys, I., Barrientos, S. A., Ward, J. E., Wallander, J., Petersson, P., & Halje, P. (2023) · Communications Biology · doi:10.1038/s42003-023-05093-6 · Cited by 42
Haller, J., Szirmai, M., Varga, B., Ledent, C. A., & Freund, T. F. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00014 · Cited by 42
Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates
Wang, M., & Arnsten, A. F. T. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1504-6 · Cited by 41
Rompala, G. R., Zsiros, V., Zhang, S., Kolata, S. M., & Nakazawa, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061278 · Cited by 41
Ruggiero, R. N., Rossignoli, M. T., Ross, J. B. D., Hallak, J. E. C., Leite, J. P., & Bueno-Júnior, L. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00399 · Cited by 41
Changes in serum levels of kynurenine metabolites in paediatric patients affected by ADHD
Evangelisti, M., Rossi, P. D., Rabasco, J., Donfrancesco, R., Lionetto, L., Capi, M., Sani, G., Simmaco, M., Nicoletti, F., & Villa, M. P. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1002-2 · Cited by 41
Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis
Veerman, S., Schulte, P., Begemann, M., Engelsbel, F., & de Haan, L. (2014) · Pharmacopsychiatry · doi:10.1055/s-0034-1383656 · Cited by 41
Higgins, G. A., Silenieks, L. B., MacMillan, C., Sevo, J., Zeeb, F. D., & Thevarkunnel, S. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.025 · Cited by 41
Kaalund, S. S., Riise, J., Broberg, B. V., Fabricius, K., Karlsen, A. S., Secher, T., Plath, N., & Pakkenberg, B. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12061 · Cited by 40
Romón, T., Mengod, G., & Adell, A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2268-6 · Cited by 40
Woodruff‐Pak, D. S., Tobia, M. J., Jiao, X., Beck, K. D., & Servatius, R. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301259 · Cited by 41
Wang, H.-X., & Gao, W. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.024 · Cited by 39
Katayama, T., Jodo, E., Suzuki, Y., Hoshino, K.-Y., Takeuchi, S., & Kayama, Y. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.002 · Cited by 39
Weise, D., Mann, J., Rumpf, J., Hallermann, S., & Claßen, J. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw212 · Cited by 39
A Role for Prefrontal Cortical NMDA Receptors in Murine Alcohol-Heightened Aggression
Newman, E. L., Terunuma, M., Wang, T. L., Hewage, N., Bicakci, M. B., Moss, S. J., DeBold, J. F., & Miczek, K. A. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.253 · Cited by 38
Arc Regulates Experience-Dependent Persistent Firing Patterns in Frontal Cortex
Ren, M., Cao, V., Ye, Y., Manji, H. K., & Wang, K. H. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-14.2014 · Cited by 38
The Glutamate Hypothesis: A Pathogenic Pathway from which Pharmacological Interventions have Emerged
Veerman, S. R. T., Schulte, P. F. J., & de Haan, L. (2014) · Pharmacopsychiatry · doi:10.1055/s-0034-1383657 · Cited by 38
Strelnikov, K. (2007) · Brain and Cognition · doi:10.1016/j.bandc.2007.04.002 · Cited by 39
Gallinat, J., Götz, T., Kalus, P., Bajbouj, M., Sander, T., & Winterer, G. (2007) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2007.19.1.59 · Cited by 37
van Wingerden, M., Vinck, M. A., Tijms, V., Ferreira, I. R. S., Jonker, A. J., & Pennartz, C. M. A. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.039 · Cited by 38
Ma, Q., Jiang, L., Chen, H., An, D., Ping, Y., Wang, Y., Dai, H., Zhang, X., Wang, Y., Chen, Z., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2207003120 · Cited by 37
meaRtools: An R package for the analysis of neuronal networks recorded on microelectrode arrays
Gelfman, S., Wang, Q., Lu, Y., Hall, D., Bostick, C. D., Dhindsa, R. S., Halvorsen, M., McSweeney, K. M., Cotterill, E., Edinburgh, T., et al. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006506 · Cited by 37
Isherwood, S. N., Pekcec, A., Nicholson, J. R., Robbins, T. W., & Dalley, J. W. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3984-0 · Cited by 37
Fejgin, K., Pålsson, E., Wass, C., Finnerty, N. J., Lowry, J., & Klamer, D. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.225 · Cited by 37
Local injection of MK801 modifies oscillatory activity in the nucleus accumbens in awake rats
Hunt, M. J., Falińska, M., & Kasicki, S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102539 · Cited by 36
Chang, C., Su, C.-L., & Gean, P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.019 · Cited by 36
Metadata
- Authors
- Jackson, M. E., Homayoun, H., & Moghaddam, B.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Moghaddam, Bita
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-05-24
- Volume
- 101
- Issue
- 22
- Pages
- 8467-8472
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC420417
- OpenAlex
- W2042422960
- Cited by
- 430
- References
- 53
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 6 · 2023: 15 · 2022: 11 · 2021: 16 · 2020: 19 · 2019: 22 · 2018: 16 · 2017: 17 · 2016: 21 · 2015: 29 · 2014: 18 · 2013: 23 · 2012: 28
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- NMDA receptor hypofunction, NMDA receptor antagonists, prefrontal cortex, neuronal firing rate, working memory deficits, schizophrenia, frontal lobe dysfunction, behavioral stereotypy
- MeSH terms
- Action Potentials, Animals, Behavior, Dose-Response Relationship, Drug, Electrophysiology, Humans, Male, Synaptic Transmission, Neurons, Schizophrenia, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Rats, Sprague-Dawley, Prefrontal Cortex, Excitatory Amino Acid Antagonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.